Share

CLINICAL TRIAL SEARCH RESULTS

NEW SEARCH
 Number: GOG 0076HH Principal Investigator: Mutch, David
Title: A Limited Access Phase I/II Trial of Paclitaxel, Cisplatin and CTEP Supplied Agent ABT-888 (Velaparib) (IND #77840) in the Treatment of Advanced, Persistent, or Recurrent Carcinomas of Cervix
Description: The purpose of the first part of this study (called Phase I) is to test how safe ABT-888 is and to determine the appropriate dose of ABT-888 to be used in the Phase II part of the study. If you enter the study on the Phase I portion, the dose of ABT-888 you will receive will depend on when you enter...MORE
___________________________________________________________________________________________________
 Number: 201109278 Principal Investigator: Esthappan, Jacqueline
Title: A Study of Novel Magnetic Resonance Imaging Sequences for Target Delineation and Prognostication in Cervical Cancer
Description: Cervical cancer is typically treated with a combination of radiation therapy and chemotherapy called cisplatin. Magnetic Resonance Imaging (or MR Imaging) and Computerized Tomography (CT) scans are typically used for planning radiation treatments. This study will evaluate if new kinds of MR images ...MORE
___________________________________________________________________________________________________
 Number: ACRIN 6682 Principal Investigator: Dehdashti, Farrokh
Title: Phase II Trial of 64Cu-ATSM PET/CT in Cervical Cancer
___________________________________________________________________________________________________
 Number: 201104322 Principal Investigator: Grigsby, Perry
Title: FDG Tumor Heterogeneity during Chemoradiation as a Predictor of Response to Concurrent Radiation Therapy and Chemotherapy in Patients with Cervical Cancer
Description: The purpose of this research study is to see if positron emission tomography (PET imaging) with 18Ffluorodeoxyglucose (FDG – a radioactive form of sugar) can help doctors determine which patients will respond best to traditional treatment versus those that need more aggressive therapy to prevent the...MORE
___________________________________________________________________________________________________
 Number: 201105400 Principal Investigator: Mutch, David
Title: Formation of a Tissue Bank for Gynecologic Malignancies
Description: The purpose of this study is to collect specimens (i.e., tissue obtained during surgery and/or blood) and related information from women who are undergoing surgery for a gynecologic condition. Specimens and related information that are collected for this research study will be used for future cance...MORE
___________________________________________________________________________________________________
 Number: 201108327 Principal Investigator: Wang-Gillam, Andrea
Title: Phase I Study of Erlotinib and Temsirolimus in Resistant Solid Malignancies
Description: The purpose of this study is to determine the maximum tolerated dose and side effects of the combination of two drugs, temsirolimus and erlotinib, used to treat solid tumor cancers. Temsirolimus is approved by the Food and Drug Administration (FDA) for treatment of renal cancer and is considered inv...MORE
___________________________________________________________________________________________________
 Number: 201107068 Principal Investigator: Lockhart, A. Craig
Title: Phase I Safety and Pharmacokinetic Study of XRP6258 (Cabazitaxel) In Advanced Solid Tumor Patients with Varying Degrees of Hepatic Impairment
Description: The purpose of this study is to determine if Cabazitaxel is a safe treatment for patients with advanced cancers of different types who also have different levels of liver dysfunction. The highest safe dose of cabazitaxel (the maximum tolerated dose, or MTD) that can be given to patients with your le...MORE
___________________________________________________________________________________________________